BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 15711804)

  • 1. Peptide motif for the rat MHC class II molecule RT1.Da: similarities to the multiple sclerosis-associated HLA-DRB1*1501 molecule.
    Duyar H; Dengjel J; de Graaf KL; Wiesmüller KH; Stevanović S; Weissert R
    Immunogenetics; 2005 Apr; 57(1-2):69-76. PubMed ID: 15711804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides.
    Vogt AB; Kropshofer H; Kalbacher H; Kalbus M; Rammensee HG; Coligan JE; Martin R
    J Immunol; 1994 Aug; 153(4):1665-73. PubMed ID: 7519208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Definition of an extended MHC class II-peptide binding motif for the autoimmune disease-associated Lewis rat RT1.BL molecule.
    Wauben MH; van der Kraan M; Grosfeld-Stulemeyer MC; Joosten I
    Int Immunol; 1997 Feb; 9(2):281-90. PubMed ID: 9040010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The peptide binding specificity of the MHC class II I-A molecule of the Lewis rat, RT1.BI.
    Reizis B; Mor F; Eisenstein M; Schild H; Stefanoviç S; Rammensee HG; Cohen IR
    Int Immunol; 1996 Dec; 8(12):1825-32. PubMed ID: 8982766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Motif analysis of HLA class II molecules that determine the HPV associated risk of cervical carcinogenesis.
    Odunsi K; Ganesan T
    Int J Mol Med; 2001 Oct; 8(4):405-12. PubMed ID: 11562779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MHC class II-regulated central nervous system autoaggression and T cell responses in peripheral lymphoid tissues are dissociated in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis.
    Weissert R; de Graaf KL; Storch MK; Barth S; Linington C; Lassmann H; Olsson T
    J Immunol; 2001 Jun; 166(12):7588-99. PubMed ID: 11390515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular determinants of peptide binding to two common rhesus macaque major histocompatibility complex class II molecules.
    Dzuris JL; Sidney J; Horton H; Correa R; Carter D; Chesnut RW; Watkins DI; Sette A
    J Virol; 2001 Nov; 75(22):10958-68. PubMed ID: 11602736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allele specificity of structural requirement for peptides bound to HLA-DRB1*0405 and -DRB1*0406 complexes: implication for the HLA-associated susceptibility to methimazole-induced insulin autoimmune syndrome.
    Matsushita S; Takahashi K; Motoki M; Komoriya K; Ikagawa S; Nishimura Y
    J Exp Med; 1994 Sep; 180(3):873-83. PubMed ID: 8064238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the encephalitogenic immune response in a model of multiple sclerosis.
    de Graaf KL; Barth S; Herrmann MM; Storch MK; Wiesmüller KH; Weissert R
    Eur J Immunol; 2008 Jan; 38(1):299-308. PubMed ID: 18050272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of naturally processed peptides eluted from HLA DRB1*0402 and *0404.
    Hayden JB; McCormack AL; Yates JR; Davey MP
    J Neurosci Res; 1996 Sep; 45(6):795-802. PubMed ID: 8892091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naturally processed peptides from two disease-resistance-associated HLA-DR13 alleles show related sequence motifs and the effects of the dimorphism at position 86 of the HLA-DR beta chain.
    Davenport MP; Quinn CL; Chicz RM; Green BN; Willis AC; Lane WS; Bell JI; Hill AV
    Proc Natl Acad Sci U S A; 1995 Jul; 92(14):6567-71. PubMed ID: 7604034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supermotifs enable natural invariant chain-derived peptides to interact with many major histocompatibility complex-class II molecules.
    Malcherek G; Gnau V; Jung G; Rammensee HG; Melms A
    J Exp Med; 1995 Feb; 181(2):527-36. PubMed ID: 7836909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Open reading frame sequencing and structure-based alignment of polypeptides encoded by RT1-Bb, RT1-Ba, RT1-Db, and RT1-Da alleles.
    Ettinger RA; Moustakas AK; Lobaton SD
    Immunogenetics; 2004 Nov; 56(8):585-96. PubMed ID: 15517241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method.
    Nielsen M; Lundegaard C; Lund O
    BMC Bioinformatics; 2007 Jul; 8():238. PubMed ID: 17608956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative molecular and three-dimensional analysis of the peptide-MHC II binding region in both human and Aotus MHC-DRB molecules confirms their usefulness in antimalarial vaccine development.
    Patarroyo ME; Cifuentes G; Baquero J
    Immunogenetics; 2006 Jul; 58(7):598-606. PubMed ID: 16791622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting Class II MHC-Peptide binding: a kernel based approach using similarity scores.
    Salomon J; Flower DR
    BMC Bioinformatics; 2006 Nov; 7():501. PubMed ID: 17105666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients.
    Valli A; Sette A; Kappos L; Oseroff C; Sidney J; Miescher G; Hochberger M; Albert ED; Adorini L
    J Clin Invest; 1993 Feb; 91(2):616-28. PubMed ID: 7679413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positional identification of RT1-B (HLA-DQ) as susceptibility locus for autoimmune arthritis.
    Haag S; Tuncel J; Thordardottir S; Mason DE; Yau AC; Dobritzsch D; Bäcklund J; Peters EC; Holmdahl R
    J Immunol; 2015 Mar; 194(6):2539-50. PubMed ID: 25672758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size.
    Chicz RM; Urban RG; Lane WS; Gorga JC; Stern LJ; Vignali DA; Strominger JL
    Nature; 1992 Aug; 358(6389):764-8. PubMed ID: 1380674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MHC class II isotype- and allele-specific attenuation of experimental autoimmune encephalomyelitis.
    de Graaf KL; Barth S; Herrmann MM; Storch MK; Otto C; Olsson T; Melms A; Jung G; Wiesmüller KH; Weissert R
    J Immunol; 2004 Aug; 173(4):2792-802. PubMed ID: 15294998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.